AG019FSH

79-57-2 | Oxytetracycline

Chemical structure of Oxytetracycline, CAS 79-57-2
AG019FSH
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 79-57-2
Catalog Number AG019FSH(AGN-PC-0UEQJM)
Chemical Name Oxytetracycline
IUPAC Name (4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide
InChI InChI=1S/C22H24N2O9/c1-21(32)7-5-4-6-8(25)9(7)15(26)10-12(21)17(28)13-14(24(2)3)16(27)11(20(23)31)19(30)22(13,33)18(10)29/h4-6,12-14,17,25-26,28,30,32-33H,1-3H3,(H2,23,31)/t12-,13-,14+,17+,21-,22+/m1/s1
InChI Key OWFJMIVZYSDULZ-PXOLEDIWSA-N
MDL Number MFCD00003700
Molecular Formula C22H24N2O9
Molecular Weight 460.4340
SMILES O=C(C(C4=O)=C(O)[C@@H](N(C)C)[C@]3([H])[C@@H](O)[C@]2([H])[C@](C)(O)C1=C(C(C2=C(O)[C@]34O)=O)C(O)=CC=C1)N
UNII SLF0D9077S
Synonyms
Bisolvomycin, Geomycin, Hydroxytetracycline, Oxyterracin, Oxyterracine, Oxytetracid, Oxytetracycline, Oxytetracycline Anhydrous, Oxytetracycline Calcium, Oxytetracycline Dihydrate, Oxytetracycline Hydrochloride, Oxytetracycline Monohydrochloride, Oxytetracycline Sulfate (2:1), Oxytetracycline, (4a beta,5 beta,5a beta,12a beta)-Isomer, Oxytetracycline, (5 beta)-Isomer, Oxytetracycline, Anhydrous, Oxytetracycline, Calcium (1:1) Salt, Oxytetracycline, Disodium Salt, Dihydrate, Oxytetracycline, Sodium Salt, Terramycin, oxytetracycline, Terramycin, 79-57-2, Oxytetracyclin, Oxitetraciclina, Oxymycin, Oxyterracine, Terrafungine, Oxytetracyclinum, Oxitetracyclin, Adamycin, Biostat, Geomycin, Ryomycin, Oxitetracyclinum, Oxyterracin, Oxyterracyne, Solkaciclina, Dabicycline, Fanterrin, Geotilin, Imperacin, Lenocycline, Oksisyklin, Proteroxyna, Riomitsin, Terramitsin, Ursocyclin, Ursocycline, Macocyn, Oxypam, Tarocyn, Tarosin, Teravit, Tetran, Antibiotic TM 25, Liquamycin LA 200, Oxytetracycline (anhydrous), Biostat PA, Oxytetracycline (Terramycin), Oxytetracycline anhydrous, Oxytetracycline amphoteric, Oxysteclin, Oxymykoin, Stevacin, Vendarcin, Oxytetracid, 5-Hydroxytetracycline, Ossitetraciclina, Pennox 200, Oxy-Kesso-tetra, Terramycin im, Oxytetracycline [INN], Berkmycen, Mycoshield TMQTHC 20, Terramycin Q50, OTC (antibiotic), Dalimycin, Oxacycline, Unimycin, Oxytetracycline calcium, Medamycin, Ossitetraciclina [DCIT], Tetracycline, 5-hydroxy-, UNII-SLF0D9077S, Oxytetracyclinum [INN-Latin], Mepatar, Stecsolin, Oxydon, Oxitetraciclina [INN-Spanish], Geomycin (Streptomyces vimosus), HSDB 3145, NCI-C56473, Oxytetracycline base, EINECS 201-212-8, LA 200, Oxytetracycline(Terramycin), BRN 2714587, C22H24N2O9, MLS000069429, SLF0D9077S, (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide, CHEBI:27701, Oxytetracycline (internal use), TM 5, 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6S,12aS)-, 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, (4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha))-, 2058-46-0, SMR000059000, NSC-9169, OGYE Selective Supplement; Oxytetracycline, Terramicina Oftalmica, 79-57-2 (ANHYDROUS), OTC, Oxytetracycline, 'can be used as secondary standard', Geomycin (Streptomyces rimosus), Embryostat, Galsenomycin, Oxitetracycline, SR-01000003006, Hydroxytetracyclinum, Oxytetracycline,(S), AC1NQXTY, AC1NQZMP, 5-Hydroxy-Tetracycline, Spectrum_001055, Opera_ID_661, AC1L1MWD, Prestwick0_000307, Prestwick1_000307, Prestwick2_000307, Prestwick3_000307, Spectrum2_000988, Spectrum3_000536, Spectrum4_000466, Spectrum5_001148, SCHEMBL2899, CHEMBL1517, DSSTox_CID_14260, DSSTox_RID_79133, DSSTox_GSID_34260, BSPBio_000274, BSPBio_002151, KBioGR_000912, KBioSS_001535, 4-14-00-02633 (Beilstein Handbook Reference), DivK1c_000225, SCHEMBL560497, SPBio_001055, SPBio_002493, BPBio1_000302, CHEMBL461529, CHEMBL1401333, DTXSID1034260, NSC9169 (HCL), SCHEMBL13169109, SCHEMBL13782651, CTK6H8882, KBio1_000225, KBio2_001535, KBio2_004103, KBio2_006671, KBio3_001651, 6153-64-6 (di-hydrate), BIB6305, IWVCMVBTMGNXQD-PXOLEDIWSA-N, NINDS_000225, OWFJMIVZYSDULZ-PXOLEDIWSA-N, BDBM241973, HY-B0275, 2058-46-0 (mono-hydrochloride), Tox21_302380, LMPK07000005, MFCD00003700, s1773, ZINC95626782, AKOS015951277, AKOS015961254, ZINC100026355, ZINC100303028, API0003726, CS-2265, DB00595, EBD2197445, MCULE-5398230579, CAS-79-57-2, IDI1_000225, NCGC00091268-04, NCGC00091268-05, NCGC00091268-06, NCGC00091268-07, NCGC00091268-08, NCGC00091268-09, NCGC00091268-11, NCGC00091268-12, NCGC00188956-01, NCGC00255168-01, AC-12777, AC-13466, AN-23998, BC202856, E703, LS-93860, S470, 7179-50-2 (calcium (1:1) salt), SBI-0051473.P003, AB1009358, AB1009512, FT-0603288, ST50307307, SW196796-3, 3,5,6,10,12,12a-hexahydroxy-6-methyl-, C06624, Oxytetra Selective Supplement, for microbiology, AB00053514_04, AB00053514_05, AB01274728-01, AB01274728_02, 135740-EP2275422A1, 135740-EP2292608A1, 6153-65-7 (di-hydrochloride salt, di-hydrate), (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-, SR-01000003006-5, 1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene, Oxytetracycline, British Pharmacopoeia (BP) Reference Standard, Oxytetracycline, European Pharmacopoeia (EP) Reference Standard, (2Z,4S,4aR,5S,5aR,6S,12aS)-2-[amino(hydroxy)methylene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione, (2Z,4S,4aR,5S,5aR,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione, (4S,4aR,5S,5aR,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione, (4s,4ar,5s,5ar,6s,12as)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4a,5a,6,12a-tetrahydrotetracene-1,3,12(2h,4h,5h)-trione, (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,11,12a-hexahydroxy-6-methyl-1,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide, (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide, (4S,5S,6S,12aS,4aR,5aR)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl -1,11-dioxo-4,5,6,12a,4a,5a-hexahydronaphthacene-2-carboxamide, 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, (4S-(4-alpha,4a-alpha,5-alpha,5a-alpha,6-beta,12a-alpha))-, Liquamycin, Bisolvomycin, Tetrachel, Abbocin, Oxytetracycline HCl, Hydroxytetracycline, glomycin, Biosolvomycin, Oxybiocycline, Aquacycline, Clinimycin, Dalinmycin, Hydrocyclin, Oxycycline, Alamycin, Chrysocin, Engemycin, Intaloxin, Liquachel, Oxamycen, Oxytetral, Oxytetrin, Oxytracyl, Terraject, Elinton, Macodyn, Otetryn, Oxatets, Oxlopar, Oxyject, Toxinal, Biotet, Oxatet, Oxytet, oxytetracyclin-, Oxyvet, Oxy-Dumocyclin, Tetra-Tablinen, Oxy-Terachel, Bi Steclin, -2-carboxamide, Oxytetracycline dihydrate, Ia-Loxin, Oxy-Rivo, Uri-Tet, Oxytetracycline.HCl, Tetran hydrochloride, Urobiotic-250, Liquamycin injectable, Oxy WS, Oxyject 100, Caswell No. 628, Oxy-Tet 50, Terramycin hydrochloride, Tetracycline, 5-oxy-, OXYTETRACYCLINE HYDROCHLORIDE, OXY-WS, Oxytetracycline, Anhydrous, Oxy-DE 250, Hydroxytetrazyklinhydrochlorid, Oxytetracycline, Sodium Salt, UNII-4U7K4N52ZM, Oxytetracyclini hydrochloridum, CCRIS 200, C22H24N2O9.ClH, UNII-X20I9EN955, Neo-oxy 100/100 MR, TM 5 (VAN), Oxytetracycline Monohydrochloride, Oxytetracycline Sulfate (2:1), NSC 9169, CID6604, NSC9169, 5-Hydroxytetracycline hydrochloride, Oxytetracycline - 100MG 100mg, Oxytetracycline, (5 beta)-Isomer, Oxytetracycline hydrochloride [JAN], C22-H24-N2-O9.Cl-H, EINECS 218-161-2, 5-Hydroxytetracycline monohydrochloride, C22-H24-N2-O9, Oxytetracycline, Calcium (1:1) Salt, CID5280972, CID5282186, CS-O-14814, EPA Pesticide Chemical Code 006308, component of Terramycin Topical Ointment, Oxytetracycline hydrochloride [USP:JAN], Oxytetracycline, disodium salt, dihydrate, Oxytetracycline hydrochloride [USAN:JAN], AI3-50164, Oxytetracycline hydrochloride (internal use), B2000, 6153-64-6, D010118, Oxytetracycline, (4a beta,5 beta,5a beta,12a beta)-Isomer, (2E,4S,4aR,5S,5aR,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione, (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide, 15251-48-6, 2-naftacenocarboxamida, 4-(dimetilamino)-1,4,4 a, 5,5 a, 6,11,12 a-octahidro-3, 5,6,10,12,12 a-hexahidroxi-6-metil-1, 11-dioxo-, (4s, 4ar, 5s, 5ar, 6s, 12as)-, 2-Naftacenocarboxamida, 4-(dimetilamino)-1,4,4 a, 5,5 a, 6,11,12 a-octahidro-3, 5,6,10,12,12 a-hexahidroxi-6-metil-1, 11-dioxo-, clorhidrato (1:1), (4S, 4aR, 5S, 5aR, 6S, 12aS)-, 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, [4S-(4.alpha.,4a.alpha.,5.alpha.,5a.alpha.,6.beta.,12a.alpha.)]-, 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, [4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha)]-, 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, dihydrate, (4S,4aR,5S,5aR,6S,12aS)-, 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, (4S,4aR,5S,5aR,6S,12aS)-, 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, (4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha))-, 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, [4S-(4.alpha.,4a.alpha.,5.alpha.,5a.alpha.,6.beta.,12a.alpha.)]-, 4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited